Office of Research Proposal Development
The Office of Research Proposal Development assists faculty in developing proposals for federal funding. The services offered by the Office of Research Proposal Development are broad, including: convening meetings of researchers for multi-investigator funding opportunities; working with investigators and sponsors to understand proposal requirements; developing a proposal preparation schedule with critical milestones and internal deadlines; creating proposal templates; gathering and formatting commonly required elements materials (biographical sketches, facilities statements, data management plan, etc.); vetting and editing all sections of the proposal.
NIH Grants
- NINDS Policy for applications requesting $500,000 or more in direct costs in any year (excluding consortium F and A)on NIH Parent R01 Notices of Funding Opportunities
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
- Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
- NIDCD Individual Fellowship Pre-Application Information Session
- Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research
- Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
- Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
- Notice of Budget Change in RFA-AI-24-006 Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed)
- Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
- Notice to Update PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)"
- Notice of Change to Key Date Section in PAR-24-080, Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
- Notice to Extend PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
- Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required)
- Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed)
- Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed)